Fighting lymphoma with targeted T-cellsTo help improve outcomes to allogenic hematopoietic stem cell transplants for patients with Epstein Barr virus (EBV)-associated lymphomas, researchers are testing transplants of immune cells specifically trained to fight cells infected with EBV. |
¿Cómo manejar el “destete” de los análogos GLP-1?
Hace 22 horas


No hay comentarios:
Publicar un comentario